GNA11 and neoplasm: Primary tumor tissue was available from 86 of these patients and tumor DNA was analyzed for the chromosome 3 status and for oncogenic mutations in GNAQ or GNA11. An oncogenic mutation in one of these genes was identified in 81 of the 86 samples (94%).